Literature DB >> 11278586

Mechanisms governing subcellular localization and function of human RGS2.

S P Heximer1, H Lim, J L Bernard, K J Blumer.   

Abstract

RGS proteins negatively regulate heterotrimeric G proteins at the plasma membrane. RGS2-GFP localizes to the nucleus, plasma membrane, and cytoplasm of HEK293 cells. Expression of activated G(q) increased RGS2 association with the plasma membrane and decreased accumulation in the nucleus, suggesting that signal-induced redistribution may regulate RGS2 function. Thus, we identified and characterized a conserved N-terminal domain in RGS2 that is necessary and sufficient for plasma membrane localization. Mutational and biophysical analyses indicated that this domain is an amphipathic alpha-helix that binds vesicles containing acidic phospholipids. However, the plasma membrane targeting function of the amphipathic helical domain did not appear to be essential for RGS2 to attenuate signaling by activated G(q). Nevertheless, truncation mutants indicated that the N terminus is essential, potentially serving as a scaffold that binds receptors, signaling proteins, or nuclear components. Indeed, the RGS2 N terminus directs nuclear accumulation of GFP. Although RGS2 possesses a nuclear targeting motif, it lacks a nuclear import signal and enters the nucleus by passive diffusion. Nuclear accumulation of RGS2 does not limit its ability to attenuate G(q) signaling, because excluding RGS2 from the nucleus was without effect. RGS2 may nonetheless regulate signaling or other processes in the nucleus.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11278586     DOI: 10.1074/jbc.M009942200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  23 in total

1.  RGS12TS-S localizes at nuclear matrix-associated subnuclear structures and represses transcription: structural requirements for subnuclear targeting and transcriptional repression.

Authors:  Tapan K Chatterjee; Rory A Fisher
Journal:  Mol Cell Biol       Date:  2002-06       Impact factor: 4.272

2.  Activation of a PTX-insensitive G protein is involved in histamine-induced recombinant M-channel modulation.

Authors:  Juan Guo; Geoffery G Schofield
Journal:  J Physiol       Date:  2002-12-15       Impact factor: 5.182

Review 3.  A finer tuning of G-protein signaling through regulated control of RGS proteins.

Authors:  Jacob Kach; Nan Sethakorn; Nickolai O Dulin
Journal:  Am J Physiol Heart Circ Physiol       Date:  2012-04-27       Impact factor: 4.733

4.  Active Galpha(q) subunits and M3 acetylcholine receptors promote distinct modes of association of RGS2 with the plasma membrane.

Authors:  Michael A Clark; Pooja R Sethi; Nevin A Lambert
Journal:  FEBS Lett       Date:  2007-01-26       Impact factor: 4.124

5.  Optogenetic Inhibition of Gαq Protein Signaling Reduces Calcium Oscillation Stochasticity.

Authors:  Pimkhuan Hannanta-Anan; Brian Y Chow
Journal:  ACS Synth Biol       Date:  2018-06-04       Impact factor: 5.110

Review 6.  How regulators of G protein signaling achieve selective regulation.

Authors:  Guo-Xi Xie; Pamela Pierce Palmer
Journal:  J Mol Biol       Date:  2006-11-15       Impact factor: 5.469

7.  Mutational analysis of the cytoplasmic tail of jaagsiekte sheep retrovirus envelope protein.

Authors:  Stacey Hull; Hung Fan
Journal:  J Virol       Date:  2006-08       Impact factor: 5.103

Review 8.  Non-canonical functions of RGS proteins.

Authors:  Nan Sethakorn; Douglas M Yau; Nickolai O Dulin
Journal:  Cell Signal       Date:  2010-04-02       Impact factor: 4.315

9.  RGS3 mediates a calcium-dependent termination of G protein signaling in sensory neurons.

Authors:  Patrizia Tosetti; Narendra Pathak; Michele H Jacob; Kathleen Dunlap
Journal:  Proc Natl Acad Sci U S A       Date:  2003-05-27       Impact factor: 11.205

Review 10.  Functional role, mechanisms of regulation, and therapeutic potential of regulator of G protein signaling 2 in the heart.

Authors:  Peng Zhang; Ulrike Mende
Journal:  Trends Cardiovasc Med       Date:  2013-08-17       Impact factor: 6.677

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.